📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Biocerna

1.1 - Company Overview

Biocerna Logo

Biocerna

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of non-invasive, readily accessible, easy-to-use, and affordable diagnostics, which it develops and commercializes.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Biocerna

Great Plains Laboratory Logo

Great Plains Laboratory

HQ: United States Website
  • Description: Provider of research-based clinical laboratory tests for nutritional and metabolic factors in chronic illnesses, including autism, AD(H)D, fibromyalgia, and gastrointestinal and neuropsychiatric disorders. Offers urine- and stool-based profiles like OAT, GI360, MycoTOX, TOXDetect, Glyphosate Test, and IgG Food MAP to assess gut health, toxins, pathogens, and food sensitivities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Great Plains Laboratory company profile →
AlliedPath Logo

AlliedPath

HQ: United States Website
  • Description: Provider of cancer-focused molecular diagnostics testing, offering an extensive menu of high-quality, solid tumor specific molecular tests to regional hospital and reference laboratories, with test results combined with expert pathology analysis into an easy-to-interpret patient report.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AlliedPath company profile →
Unity Biotechnology Logo

Unity Biotechnology

HQ: United States Website
  • Description: Provider of therapeutics to prevent, halt, and reverse diseases of aging, with candidates for age-related eye diseases and neurodegeneration: UBX1325, a Bcl-xL inhibitor in clinical development that selectively eliminates senescent cells in diseased vasculature for conditions including diabetic macular edema; UBX2050, an investigational Tie2-activating monoclonal antibody; and UBX2089, a recombinant α-Klotho protein.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Unity Biotechnology company profile →
Isarna Therapeutics Logo

Isarna Therapeutics

HQ: Germany Website
  • Description: Provider of selective TGF-β inhibitors and antisense oligonucleotide therapies, advancing a pipeline of novel oligonucleotides and combination modalities. Offerings include ISTH0036, an antisense oligonucleotide in Phase 2a for ophthalmic conditions, and therapies targeting TGF-β signaling for fibrotic liver disease, NASH, and various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Isarna Therapeutics company profile →
Unilabs Logo

Unilabs

HQ: Switzerland Website
  • Description: Provider of outsourced diagnostic services, including clinical laboratory testing and medical diagnostic imaging. Operates over 112 laboratories and 43 imaging units with a catalogue of more than 2,500 diagnostic tests. Headquartered in Geneva, the company is one of Europe's leading providers and serves private and public healthcare providers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Unilabs company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Biocerna

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Biocerna

2.2 - Growth funds investing in similar companies to Biocerna

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Biocerna

4.2 - Public trading comparable groups for Biocerna

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Biocerna

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Biocerna

What does Biocerna do?

Biocerna is a provider of non-invasive, readily accessible, easy-to-use, and affordable diagnostics, which it develops and commercializes.

Who are Biocerna's competitors?

Biocerna's competitors and similar companies include Great Plains Laboratory, AlliedPath, Unity Biotechnology, Isarna Therapeutics, and Unilabs.

Where is Biocerna headquartered?

Biocerna is headquartered in United States.

How many employees does Biocerna have?

Biocerna has 1,000 employees 🔒.

When was Biocerna founded?

Biocerna was founded in 2010 🔒.

What sector and industry vertical is Biocerna in?

Biocerna is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Biocerna

Who are the top strategic acquirers in Biocerna's sector and industry

Top strategic M&A buyers and acquirers in Biocerna's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Biocerna?

Top strategic M&A buyers groups and sectors for Biocerna include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Biocerna's sector and industry vertical

Which are the top PE firms investing in Biocerna's sector and industry vertical?

Top PE firms investing in Biocerna's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Biocerna's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Biocerna's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Biocerna's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Biocerna include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Biocerna's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Biocerna?

The key public trading comparables and valuation benchmarks for Biocerna include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Biocerna for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Biocerna with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Biocerna's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Biocerna with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Biocerna's' sector and industry vertical?

Access recent funding rounds and capital raises in Biocerna's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Biocerna